A Covid-19 patient who was administered with DRDO’s 2-DG drug dies in JMCH

Guwahati, (NKTV): In a recent Development, a Covid-19 patient, who was administered the new 2-DG (2-Deoxy-D-Glucose), died on Sunday night due to post-Covid-19 complications. The patient, a young male, was undergoing treatment at the Jorhat Medical College Hospital (JMCH) for Covid-19. He was the first person in the state to be administered with the new drug.

The anti-Covid-19 drug is developed by the defence research and development organisation (DRDO) in collaboration with Dr Reddy’s Laboratories. The drug comes in powder form in a sachet, which is taken orally by dissolving it in water. The patient reportedly procured the drug from his uncle who works at the DRDO in Hyderabad as a senior scientist.

He later dispatched it JMCH and requested to be administered. According to superintendent of JMCH Dr. Purnima Baruah, the patient had been administered the drug since May 22 and had tested negative in RT-PCR test after completion of the doses. He was then shifted to the general ICU from Covid-19 ICU but on Sunday night, he died of post-Covid-19 complications, she said. DRDO chairman Dr G Satheesh Reddy said the drug had gone through complete trials across 30 hospitals, on a large number of patients.

82 COMMENTS

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular

More like this
Related

মঙলদৈৰ মোৱামাৰীত গাৰ নোম শিঁয়ৰি উঠা ঘটনা

মঙলদৈৰ মোৱামাৰীত গাৰ নোম শিঁয়ৰি উঠা ঘটনা। প্ৰেম কৰাৰ...

গুৱাহাটীত উপস্থিত কংগো গণৰাজ্যৰ ৰাণী ডায়াম্বি কাবাটুছুইলা

বালিপাৰা ফাউণ্ডেচনে পূৰ্বৰ দৰে এইবাৰো অহা ২৬-২৭ নৱেম্বৰত...

বালিপাৰা ফাউণ্ডেশ্যনৰ দ্বাদশ পূব হিমালয়ান প্ৰকৃতিবিজ্ঞান মঞ্চ

গুৱাহাটীত উপস্থিত কংগো গণৰাজ্যৰ ৰাণী ডায়াম্বি কাবাটুছুইলা বালিপাৰা ফাউণ্ডেচনে পূৰ্বৰ...

পণ্ডিত হেমচন্দ্ৰ গোস্বামী ফাউণ্ডেশ্যনৰ উদ্যোগত ৱাশ্বিংটন ডি চিত ভাষা গৌৰৱ সপ্তাহ উদযাপন

অসমীয়া ভাষাই ধ্ৰুপদী ভাষাৰ মৰ্যাদা লাভ কৰা উপলক্ষে আমেৰিকা...